Prognostic Value of Early S100 Calcium Binding Protein B and Neuron-Specific Enolase in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage: A Pilot Study

World Neurosurg. 2017 Dec:108:669-675. doi: 10.1016/j.wneu.2017.09.074. Epub 2017 Sep 21.

Abstract

Background: This prospective study was undertaken to investigate the value of early S100 calcium binding protein B (S100B) and neuron-specific enolase (NSE) in prognosticating outcome in patients with poor-grade aneurysmal subarachnoid hemorrhage and to develop a statistical model and cutoff values for clinical practice.

Methods: Between 2012 and 2014, patients with poor-grade subarachnoid hemorrhage (Hunt and Hess grade 3-5) who were admitted within 24 hours after hemorrhage were prospectively enrolled. Serum NSE and S100B levels were assayed once daily during the first 3 days after hemorrhage. Patient characteristics, Glasgow Coma Scale score, Hunt and Hess grade, and Fisher grade at admission were recorded. Glasgow Outcome Scale (GOS) score was obtained at 6 months and dichotomized as poor (score 1-3) or good (score 4-5). Logistic regression and receiver operating characteristic curve were used to assess the value of S100B and NSE in predicting outcome, and cutoff values were calculated using conditional interference trees.

Results: The study included 52 patients. Hunt and Hess grade was 3 in 23 patients, 4 in 15 patients, and 5 in 14 patients. S100B range was 0.07-5.62 μg/L (mean 0.87 μg/L ± 1.06). NSE range was 5.7-94.2 μg/L (mean 16.1 μg/L ± 10.5). At 6-month follow-up, 23 patients (44.2%) had a poor outcome, and 29 patients (55.8%) had a good outcome. Both S100B at day 1 (P = 0.004; cutoff 0.202 μg/L) and NSE at day 1 (P = 0.047; cutoff 9.4 μg/L) predicted good outcome with a specificity of 100%. The specificity of mean S100B in detecting patients with poor outcome reached 100% (P = 0.003) when combined with mean NSE levels.

Conclusions: S100B and NSE measured during the first 3 days after hemorrhage showed, separately and combined, a significant predictive value in prognosticating clinical outcome in patients with poor-grade subarachnoid hemorrhage. A multicenter study with a large patient cohort is necessary to validate the above-mentioned cutoff values for clinical practice.

Keywords: Intracranial aneurysm; NSE; S100; Subarachnoid hemorrhage.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Female
  • Follow-Up Studies
  • Glasgow Coma Scale
  • Glasgow Outcome Scale
  • Humans
  • Intracranial Aneurysm / blood*
  • Intracranial Aneurysm / therapy
  • Logistic Models
  • Male
  • Middle Aged
  • Phosphopyruvate Hydratase / blood*
  • Pilot Projects
  • Prognosis
  • Prospective Studies
  • ROC Curve
  • S100 Proteins / blood*
  • Subarachnoid Hemorrhage / blood*
  • Subarachnoid Hemorrhage / therapy
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • S100 Proteins
  • Phosphopyruvate Hydratase